Clinical Research Directory

Inclusion Criteria: 1. Adults aged between 18 and 80 years old. 2. Experiencing persistant subjective tinnitus for at least 3 months. 3. A score of 38 or more on THI. 4. 50 dB HL or less on the average pure tone threshold (0.5, 1, 2kHz) of the worse ear. 5. Voluntarily participate in the study and sign the informed consent form. 6. Have normal mental status and cognitive function, and be able to cooperate with the research process. Exclusion Criteria: 1. Diagnosis of Meniere's disease, conductive hearing loss or objective tinnitus. 2. History of epilepsy or stroke. 3. Diagnosis of acoustic neuroma. 4. Severe sensorineural hearing loss. 5. Surgically or traumatically implanted ferromagnetic foreign bodies, including but not limited to pacemakers, neurostimulators, prosthetic metal heart valves, aneurysm clips (non-titanium alloy), intraocular metal foreign bodies, cochlear implants, metal prostheses, metal joints, fixed steel plates or steel pins. 6. Patients with active metal foreign bodies (metal implants, dentures, contraceptive rings), insulin pumps, etc., who have been evaluated in detail and are at risk for rTMS treatment. 7. Patients taking vestibular sedatives, antipsychotics, anxiolytics, antiepileptics, and ototoxic drugs. 8. Patients with a recent history of alcohol or drug abuse 9. Bell's palsy 10. Acute ear infection within the last 1 month 11. Inability to cooperate or complete the study process 12. Participation in another clinical trial within the last month. 13. Have any condition that may affect compliance or safety 14. Any other condition that, in the opinion of the investigator, makes enrollment in the study inappropriate.